Genetics of Appendix Cancer Study
Public ClinicalTrials.gov record NCT05734430. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Genetics of Appendix Cancer: The GAP Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.
Study identification
- NCT ID
- NCT05734430
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 700 participants
Conditions and interventions
Conditions
- Appendix Cancer
- Appendiceal Cancer
- Appendiceal Neoplasms
- Appendiceal Mucinous Neoplasm
- Appendiceal Adenocarcinoma
- Appendiceal Carcinoid Tumor
- Appendiceal Neoplasm Malignant Secondary
- Appendix Adenocarcinoma
- Appendix Mucinous Neoplasm
- Appendix Tumor
- Appendix Cancer Metastatic
- Appendix NET
- Low-Grade Appendix Mucinous Neoplasm
- High Grade Appendix Mucinous Neoplasm
- High Grade Appendix Mucinous Adenocarcinoma
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 10, 2022
- Primary completion
- Oct 31, 2032
- Completion
- Oct 31, 2034
- Last update posted
- Apr 17, 2025
2022 – 2034
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05734430, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 17, 2025 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05734430 live on ClinicalTrials.gov.